Concerns about intentional paracetamol poisoning, maximum pack sizes to be reduced in Australia Media release 25 February 2023 Pages: 1 - 1
Crizanlizumab not superior to placebo and has higher rates of grade ≥3 AEs News item 25 February 2023 Pages: 2 - 2
Hydroxyethyl starch solution for infusion: risk of kidney injury, reminder of risk minimisation measures News item 25 February 2023 Pages: 3 - 3
Pregabalin use during pregnancy may cause congenital abnormalities News item 25 February 2023 Pages: 4 - 4
Baricitinib-related AEs in patients with severe alopecia areata Clinical study 25 February 2023 Pages: 6 - 6
Biological and target synthetic DMARDs have differing infection risks Clinical study 25 February 2023 Pages: 7 - 7
Hypertension increases risk of romosozumab cardiac and cerebrovascular events Clinical study 25 February 2023 Pages: 8 - 8
More AEFIs reported after COVID-19 vaccination in females than in males Clinical study 25 February 2023 Pages: 9 - 9
Nivolumab-related myocarditis, pericarditis, pericardial effusion Clinical study 25 February 2023 Pages: 10 - 10
Outpatient medication errors common among children with leukaemia or lymphoma Clinical study 25 February 2023 Pages: 11 - 11
PEG may increase risk of drug-related hypersensitivity reactions Clinical study 25 February 2023 Pages: 12 - 12
Correction to: Reactions Weekly, 1941, Issue 1, pages 258-346. Unknown 25 February 2023 Pages: 13 - 13
